Final Condition of HIV Patients Infected with COVID-19 after Receiving Hospital Treatment: A Systematic Review
Downloads
Introduction: Coronavirus disease 2019 (COVID-19) can attack anyone, including those who have human immunodeficiency virus (HIV) due to low immune systems. This study aimed to evaluate the final condition of people living with human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) (PLWHA) who received treatment at the hospital.
Methods: A literature investigation of the last three years (2020-2022) were inquired. Electronic databases (Science Direct, Scopus, ProQuest) with case series or case report designs were examined. The titles, abstracts, and full texts were screened to obtain relevant studies. Data tabulation and narrative analysis were conducted, resulting in 14 studies that met the inclusion criteria. Most of them were case series and case report methods. Each study had different numbers of patients and criteria discussing COVID-19 infection in HIV patients.
Results: A total of 14 reviewed studies revealed that HIV patients with COVID-19 could recover from the infection if proper treatments were performed. Some articles also stated that self-isolation at home can manage HIV-infected patients who are not yet severe. In the case of patients with severe infections, intensive care is performed using supplemental oxygen or a ventilator to prevent respiratory failure or acute respiratory distress.
Conclusion: COVID-19 can worsen the condition of patients with HIV if not appropriately treated. Otherwise, if the proper treatment is properly performed, it can cure the infection.
Radke RM, Frenzel T, Baumgartner H, et al. Adult Congenital Heart Disease and the COVID-19 Pandemic. Heart 2020; 106: 1302–1309. [PubMed]
Pathan RK, Biswas M, Khandaker MU. Time Series Prediction of COVID-19 by Mutation Rate Analysis Using Recurrent Neural Network-Based LSTM Model. Chaos, Solitons & Fractals 2020; 138: 110018. [PubMed]
Pradipta J, Nazaruddin AM. Antipanik! Buku Panduan Virus Corona. Jakarta: PT Elex Media Komputindo, 2020.
Sutaryo. Buku Praktis Penyakit Virus Corona 19 (COVID-19). Yogyakarta: UGM Press, 2020.
Jordan RE, Adab P, Cheng KK. COVID-19: Risk Factors for Severe Disease and Death. BMJ 2020; 368. Epub ahead of print March 2020. [PubMed]
Chakraborty I, Maity P. COVID-19 Outbreak: Migration, Effects on Society, Global Environment And Prevention. Sci Total Environ 2020; 728: 138882. [PubMed]
Gudipati S, Brar I, Murray S, et al. Descriptive Analysis of Patients Living with HIV Affected by COVID-19. J Acquir Immune Defic Syndr 2020; 85: 123. [PubMed]
Indonesia KKR. COVID-19. Jakarta, https://p2ptm.kemkes.go.id/profil-p2ptm/daftar-informasi-publik/covid-19 (2021).
Fitzpatrick ME, Kunisaki KM, Morris A. Pulmonary Disease in HIV-Infected Adults in the Era of Antiretroviral Therapy. AIDS 2018; 32: 277–292. [PubMed]
Boulle A, Davies MA, Hussey H, et al. Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa. Clin Infect Dis 2021; 73: e2005–e2015. [PubMed]
Blanco JL, Ambrosioni J, Garcia F, et al. COVID-19 in Patients with HIV: Clinical Case Series. Lancet HIV 2020; 7: e314-e316. Epub ahead of print 2020. [PubMed]
Byrd KM, Beckwith CG, Garland JM, et al. SARS-CoV-2 and HIV Coinfection: Clinical Experience from Rhode Island, United States. 2020; 23: e25573. [PubMed]
Ridgway JP, Farley B, Benoit JL, et al. A Case Series of Five People Living with HIV Hospitalized with COVID-19 in Chicago, Illinois. AIDS Patient Care STDS 2020; 34: 331–335. [PubMed]
Collins LF, Moran CA, Oliver NT, et al. Clinical Characteristics, Comorbidities, and Outcomes among Persons with HIV Hospitalized with Coronavirus Disease 2019 in Atlanta, Georgia. AIDS 2020; 34: 1789–1794. [PubMed]
Cooper TJ, Woodward BL, Alom S, et al. Coronavirus Disease 2019 (COVID-19) Outcomes in HIV/AIDS Patients: A Systematic Review. HIV Med 2020; 21: 567–577. [PubMed]
Calza L, Bon I, Tadolini M, et al. COVID-19 in Patients with HIV-1 Infection: A Single-Centre Experience in Northern Italy. Infection 2021; 49: 333–337. [PubMed]
Suwanwongse K, Shabarek N. Variation in Mortality of HIV/SARS-CoV-2 Coinfected Patients in the Bronx, New York City. J Med Virol 2021; 93: 603–605. [PubMed]
Baluku JB, Mwebaza S, Ingabire G, et al. HIV and SARS"CoV"2 Co"Infection: A Case Report from Uganda. J Med Virol 2020; 92: 2351–2353. [PubMed]
Benkovic S, Kim M, Sin E. 4 Cases: HIV and SARS"CoV"2 Co"Infection in Patients from Long Island, New York. J Med Virol 2020; 92: 2338–2340. [PubMed]
Nakamoto T, Kutsuna S, Yanagawa Y, et al. A Case of SARS"CoV"2 Infection in An Untreated HIV Patient in Tokyo, Japan. J Med Virol 2021; 93: 40–42. [PubMed]
Menghua W, Xin Z, Jianwei L, et al. Case Report: One Case of Coronavirus Disease 2019 (COVID-19) in a Patient Co-Infected by HIV with a Normal CD4+T Cell Count. AIDS Res Ther 2020; 17: 1–4. [PubMed]
Isernia V, Julia Z, Gac S Le, et al. SARS-COV2 Infection in 30 HIV-Infected Patients Followed-Up in a French University Hospital. Int J Infect Dis 2020; 101: 49–51. [PubMed]
Wei G, Huiling W, Hua B, et al. [Quick Community Survey on the Impact of COVID-19 Outbreak for the Healthcare of People Living with HIV]. Zhonghua Liu Xing Bing Xue Za Zhi 2020; 41: 662–666. [PubMed]
Karcher DS. From HIV to Coronavirus Disease 2019 (COVID-19) Hematologic Complications in Viral Pandemics. Arch Pathol Lab Med 2022; 146: 433–439. [PubMed]
Copyright (c) 2023 Elin Hidayat, Abu Bakar, Nursalam Nursalam, Retno Indarwati, Herminia Maria
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.